ABBV vs GOOGL: Which Is the Better Buy?
Side-by-side comparison of AbbVie Inc. and Alphabet Inc. โ fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
AbbVie Inc. ยท Healthcare
$261.70
-1.0% upside to fair value
Med Conviction
Grade C
High Quality
VS
Alphabet Inc. ยท Communication Services
$342.36
+16.6% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
GOOGL has more upside to fair value
(+16.6%).
These are model outputs โ not personalized investment advice.
See all research โ
Valuation & Fundamentals
| Metric |
ABBV |
GOOGL |
| Current Price |
$261.70 |
$342.36 |
| Fair Value Estimate |
$259.04 |
$399.26 |
| Upside to Fair Value |
-1.0%
|
+16.6%
|
| Market Cap |
$462.4B |
$4,143.3B |
| Forward P/E |
โ
|
โ
|
| EV / EBITDA |
24.8x
|
12.9x
|
| Price / Sales |
7.2x
|
9.3x
|
| Price / FCF |
23.6x
|
78.1x
|
| Revenue Growth YoY |
+10.2%
|
+24.2%
|
| Gross Margin |
71.5%
|
60.9%
|
| Operating Margin |
29.3%
|
33.1%
|
| Return on Equity |
-136.5%
|
50.8%
|
| Dividend Yield |
2.61% |
0.25% |
| FCF Yield |
4.25%
|
1.28%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
AbbVie is a diversified branded-biopharma company spanning immunology, neuroscience, oncology and aesthetics, with high-margin TTM economics including a 71.5% gross margin and 29.3% operating margin. Its successor immunology franchises are performing strongly: Q2 2026 revenue rose 10.2% year over year, with Skyrizi up 24.4% to $5.505 billion and Rinvoq up 24.5% to $2.525 billion, helping offset aโฆ
Alphabet is the parent of Google Services (Search, YouTube, Android, Chrome, hardware, and the Play store), Google Cloud, and Other Bets, and it remains one of the highest-quality large-cap franchises in the market, with a TTM gross margin of 60.9%, TTM operating margin of 33.1%, TTM net margin of 54.8%, and a 50.8% return on equity. Revenue growth in the most recent quarter was 24.2% year over yโฆ
Accumulation Zones
| Metric |
ABBV |
GOOGL |
| Zone Low |
$194.28 |
$299.44 |
| Zone High |
$220.18 |
$339.37 |
| In Buy Zone? |
No
|
No
|